End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -.--% | -.--% |
05-02 | Attana AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-30 | BioInvent Announces Evaluating Attana Technology | CI |
Sales 2022 | 13.11M 1.24M 1.15M 1.69M | Sales 2023 | 6.82M 644K 600K 880K | Capitalization | 26.99M 2.55M 2.38M 3.48M |
---|---|---|---|---|---|
Net income 2022 | -14M -1.32M -1.23M -1.81M | Net income 2023 | -13M -1.23M -1.14M -1.68M | EV / Sales 2022 | 3.42 x |
Net Debt 2022 | 3.24M 306K 285K 419K | Net Debt 2023 | 3.18M 300K 280K 411K | EV / Sales 2023 | 4.43 x |
P/E ratio 2022 |
-2.84
x | P/E ratio 2023 |
-1.96
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 43.5% |
Managers | Title | Age | Since |
---|---|---|---|
Marcus Söderberg
CEO | Chief Executive Officer | - | 23-09-17 |
Founder | 54 | 01-12-31 | |
Anders Ulrikson
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 16-12-31 | |
Arne Nabseth
CHM | Chairman | 61 | 15-09-30 |
Founder | 54 | 01-12-31 |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.98% | 1.02B | |
-15.70% | 136M | |
-22.22% | 56.93M |